Vitalhub (TSE:VHI – Get Free Report) released its quarterly earnings results on Thursday. The company reported C$0.04 earnings per share (EPS) for the quarter, FiscalAI reports. The firm had revenue of C$31.91 million during the quarter. Vitalhub had a net margin of 5.89% and a return on equity of 2.79%.
Vitalhub Stock Performance
Shares of VHI traded down C$0.01 during mid-day trading on Thursday, reaching C$8.00. 135,700 shares of the company were exchanged, compared to its average volume of 292,685. Vitalhub has a 52 week low of C$6.46 and a 52 week high of C$9.81. The stock has a market capitalization of C$506.71 million, a PE ratio of 66.67, a PEG ratio of 1.18 and a beta of 1.37. The business has a 50 day simple moving average of C$7.58 and a two-hundred day simple moving average of C$7.59.
Analyst Ratings Changes
Separately, Canaccord Genuity Group set a C$15.00 price objective on shares of Vitalhub and gave the stock a “buy” rating in a research note on Friday, August 28th. Six analysts have rated the stock with a Buy rating. Based on data from MarketBeat.com, Vitalhub presently has a consensus rating of “Buy” and a consensus target price of C$12.67.
About Vitalhub
VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.
Read More
- Five stocks we like better than Vitalhub
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
